Abstract
Clozapine may produce agranulocytosis in 1–2% of patients treated with it for 4 weeks or longer. Three mechanisms have been suggested: a direct toxic effect of metabolite of clozapine, an immunologic mechanism or a combination of both. N-desmethylclozapine, the major metabolite of clozapine, has been reported to be more toxic than clozapine itself (Gerson et al., 1994). In this study, plasma levels of clozapine and desmethylclozapine were measured in five patients who developed agranulocytosis. The levels of both parent compound and metabolite were within the range found in other patients and below the toxic range. If a toxic mechanism is involved in clozapine-induced agranulocytosis, an additional vulnerability factor must be important.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Additional information
Address reprint requests to: Mitsuru Hasegawa, M.D., Laboratory of Biological Psychiatry, Department of Psychiatry, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106-5000.
Rights and permissions
About this article
Cite this article
Hasegawa, M., Cola, P. & Meltzer, H. Plasma Clozapine and Desmethylclozapine Levels in Clozapine-Induced Agranulocytosis. Neuropsychopharmacol 11, 45–47 (1994). https://doi.org/10.1038/npp.1994.34
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/npp.1994.34
Keywords
This article is cited by
-
A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions
Psychopharmacology (2021)
-
Clozapine and desmethylclozapine: correlation with neutrophils and leucocytes counting in Mexican patients with schizophrenia
BMC Psychiatry (2019)
-
Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia
Molecular Psychiatry (2017)
-
Structure and toxicity of clozapine and olanzapine on agranulocytosis
Medicinal Chemistry Research (2016)
-
Development and validation of an HPLC method for the simultaneous determination of clozapine and desmethylclozapine in plasma of schizophrenic patients
Chromatographia (1999)